Mexico provides a full spectrum of Parkinson’s disease treatments, including gold-standard pharmacological protocols and advanced neurosurgery. Patients access deep brain stimulation (DBS) and MR-guided focused ultrasound (MRgFUS) at JCI-accredited facilities. Regenerative medicine using COFEPRIS-approved mesenchymal stem cells is also a primary option in specialized hubs.
- Surgical interventions: DBS and MRgFUS target motor symptoms for medication-resistant patients.
- Regenerative therapy: IV drips of 100 million mesenchymal stem cells cost approximately $5,000.
- Pharmacological care: Levodopa/carbidopa and dopamine agonists follow international movement disorder protocols.
- Specialized diagnostics: Care begins with EEG, brain MRI, and complex neurological diagnostics.
Bookimed Expert Insight: While many seek surgery, Mexico’s real strength is the volume of regenerative medicine packages. Clinics like Rehabilitata and Aura Regenerative Center bundle 100 million stem cells with 5-star hotel stays and VIP transfers for around $5,000 to $9,500. This is significantly more comprehensive than standard clinical settings, as it integrates recovery logistics into the medical price.
Patient Consensus: Patients note that Levodopa combinations are much more affordable than in the US. However, they emphasize the importance of choosing clinics in major urban centers like Mexico City or Monterrey to ensure consistent access to English-speaking specialists.